RVMD · Revolution Medicines Inc
United States · RS rating 81 · As of 2026-11-03
| Price | 194.23 USD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 42 / 63 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 48 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -15.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +12.2% |
| Market cap (USD) | $28.4B |